Visualizing the conversion of carbamazepine in aqueous suspension with and without the presence of excipients: A single crystal study using SEM and Raman microscopy

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 64, Issue 3, 2006, Pages 326-335

  Tian, F ^a   Sandler, N ^a   Gordon, K C ^a   McGoverin, C M ^a   Reay, A ^a   Strachan, C J ^b   Saville, D J ^a   Rades, T ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Carbamazepine; Dihydrate; Excipient; Hydration; Raman microscopy; Scanning electron microscopy; Single crystal

Indexed keywords

CARBAMAZEPINE; CARBOXYMETHYLCELLULOSE; EXCIPIENT; HYDROXYPROPYLCELLULOSE; MACROGOL; METHANOL; POVIDONE; WATER;

AQUEOUS SOLUTION; ARTICLE; COMPUTER PROGRAM; CRYSTAL; DISPERSION; DRUG STRUCTURE; ELECTRON MICROSCOPY; HYDRATION; IMMERSION; PH; SCANNING ELECTRON MICROSCOPY; SUSPENSION;

CARBAMAZEPINE; CARBOXYMETHYLCELLULOSE; CARBOXYMETHYLCELLULOSE SODIUM; CELLULOSE; CRYSTALLIZATION; EXCIPIENTS; FOURIER ANALYSIS; MICROSCOPY, ELECTRON, SCANNING; MODELS, MOLECULAR; MOLECULAR STRUCTURE; POLYETHYLENE GLYCOLS; POVIDONE; SOLUTIONS; SPECTRUM ANALYSIS, RAMAN; TIME FACTORS; WATER;

EID: 33750072597     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2006.05.014     Document Type: Article

References (31)

1. Newman A.W., and Brittain H.G. Particle morphology: optical and electron microscopies. In: Brittain H.G. (Ed). Physical Characterization of Pharmaceutical Solids (1995), Marcel Dekker, Inc., New York, NY, USA 127-156
2. Luhtala S. Effect of sodium lauryl sulphate and polysorbate 80 on crystal growth and aqueous solubility of carbamazepine. Acta Pharm. Nordica 4 (1992) 85-90
3. Naima Z., Siro T., Juan-Manuel G.-D., Chantal C., Rene C., and Jerome D. Interactions between carbamazepine and polyethylene glycol (PEG) 6000: characterizations of the physical, solid dispersed and eutectic mixtures. Eur. J. Pharm. Sci. 12 (2001) 395-404
4. Noushin B., Ali N., and Rassoul D. The effect of solvent and crystallization conditions on habit modification of carbamazepine, Daru. J. Faculty Pharm. 9 (2001) 12-22
5. Sethia S., and Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int. J. Pharm. 272 (2004) 1-10
6. Laine E., Tuominen V., IIvessalo P., and Kahela P. Formation of dihydrate from carbamazepine anhydrate in aqueous conditions. Int. J. Pharm. 20 (1984) 307-314
7. Yong W.W.L., and Suryanarayanan R. Kinetics of transition of anhydrous carbamazepine to carbamazepine dihydrate in aqueous suspensions. J. Pharma. Sci. 80 (1991) 496-500
8. Brittain H.G. Fluoresence studies of the transformation of carbamazepine anhydrate form III to its dihydrate phase. J. Pharm. Sci. 93 (2003) 375-383
9. Tian F., Zeitler J.A., Strachan C.J., J Saville D., Gordon C.K., and Rades T. Characterizing the conversion kinetics of carbamazepine polymorphs to the dihydrate in aqueous suspension using Raman spectroscopy. J. Pharm. Biomed. Anal. 40 (2006) 271-280
10. Rodríguez-Hornedo N.K., and Murphy D. Surfactant-facilitated crystallization of dihydrate carbamazepine during dissolution of anhydrous polymorph. J. Pharm. Sci. 93 (2003) 449-460
11. D.J. Saville, F. Tian, K.C. Gordon, C.J. Strachan, J.A. Zeitler, T. Rades, Conversio of carbamazepine polymorphs to the dihydrate in aqueous suspension: inhibition by various excipients, in: Proceedings of the Annual Conference of the Australasian Pharmaceutical Science Association, Melbourne, Australia, 2005.
12. Samaha M.W., and Gadalla M.A.F. Solubilization of carbamazepine by different classes of nonionic surfactants and a bile salt. Drug Dev. Ind. Pharm. 13 (1987) 93-112
13. Otsuka M., Ohfusa T., and Matsuda Y. Effect of binders on polymorphic transformation kinetics of carbamazepine in aqueous solution. Colloids Surf. B: Biointerfaces 17 (2000) 145-152
14. Otsuka M., Ohfusa T., and Matsuda Y. Effect of environmental humidity on the transformation pathway of carbamazepine polymorphic modifications during grinding. Colloids Surf. B 13 (1999) 263-273
15. Otsuka M., Ishii M., and Matsuda Y. Effect of surface modification on hydration kinetics of carbamazepine anhydrate using isothermal microcalorimetry. AAPS PharmSciTech [electronic resource] 4 (2003) E5
16. Perissutti B., Rubessa F., Moneghini M., and Voinovich D. Formulation design of carbamazepine fast-release tablets prepared by melt granulation technique. Int. J. Pharm. 256 (2003) 53-63
17. Katzhendler I., Ito S., Itai S., and Yamamoto K. Investigating the structure and properties of hydrates hydroxypropyl methylcellulose and egg albumin matrices containing carbamazepine: EPR and NMR study. Pharm. Res. 17 (2000) 1299-1308
18. Murphy D., Rodríguez-Cintrón F., Langevin B., Kelly R.C., and Rodriguez-Hornedo N. Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice diorder. Int. J. Pharm. 246 (2002) 121-134
19. Sarkari M., Brown J., Chen X., Swinnea S., Williams R.O., and Johnston K.P. Enhanced drug dissolution using evaporative precipitation into aqueous solution. Int. J. Pharm. 243 (2002) 17-31
20. Katzhendler I., Azoury R., and Friedman M. The effect of egg albumin on the crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets and in aqueous solutions. J. Controlled Release 65 (2000) 331-343
21. Kobayashi Y., Ito S., Itai S., and Yamamoto K. Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate. Int. J. Pharm. 193 (2000) 137-145
22. Himes V.L., Mighell A.D., and De Camp W.H. Structure of carbamazepine: 5H-dibenz[b,f]azepine-5-carboxamide. Acta Crystallogr. B37 (1981) 2245-2248
23. Ester G.R., Price R., and Halfpenny P.J. The relationship between crystal growth and defect structure: a study of potassium hydrogen phthalate using X-ray topography and atomic force microscopy. J. Phys. D: Appl. Phys. 32 (1999) A128-A132
24. Myerson A.S., Decker S.E., and Fan W. Solvent selection and batch crystallization. Ind. Eng. Chem. Process Des. Dev. 25 (1986) 925-929
25. Stoica C., Verwer P., Meekes H., van Hoof P.J.C.M., Kaspersen F.M., and Vlieg E. Understanding the effect of a solvent on the crystal habit. Cryst. Growth Des. 4 (2004) 765-768
26. Marcus Y. The properties of organic liquids that are relevant to their use as solvating solvents. Chem. Soc. Rev. 22 (1993) 409-416
27. Han J., and Suryanarayanan R. Influence of environmental conditions on the kinetics and mechanism of dehydration of carbamazepine dihydrate. Pharm. Dev. Technol. 3 (1998) 587-596
28. McMahon L.E., Timmins P., Williams A.C., and York P. Characterization of dihydrates prepared from carbamazepine polymorphs. J. Pharm. Sci. 85 (1996) 1064-1069
29. Anquetil P.A., Brenan C.J.H., Marcolli C., and Hunter I.W. Laser Raman spectroscopic analysis of polymorphic forms in microliter fluid volumes. J. Pharm. Sci. 92 (2002) 149-160
30. Smith D.C., and Carabatos-Nedelec C. Raman spectroscopy applied to crystals. In: Lewis I.R., and Edwards H.G.M. (Eds). Handbook of Raman spectroscopy: from the Research Laboratory to the Process Line (2001), Marcel Dekker, Inc., New York, NY, USA 349-422
31. Salameh A.K., and Taylor L.S. Physical stability of crystal hydrates and their anhydrates in the presence of excipients. J. Pharm. Sci. 95 (2005) 446-461